Managing the consequences of cancer treatments Clinical case session

Live Q&A

Lecture Time
15:35 - 15:45
Speakers
  • Susana Banerjee (London, United Kingdom)
Room
Auditorium 1A
Date
Sat, 18.06.2022
Time
14:15 - 15:45
Eisai - Recent advances in the management of endometrial cancer and their impact on the clinical practice Industry satellite symposium

Patient case study & discussion: The challenges of managing adverse events

Lecture Time
18:40 - 18:55
Speakers
  • Philipp Harter (Essen, Germany)
Room
Auditorium 1A
Date
Fri, 17.06.2022
Time
18:00 - 19:00
Shall all patients regardless of biomarker status receive immunotherapy in cervical cancer? Controversy session

Second vote and conclusions

Lecture Time
15:40 - 15:50
Speakers
  • Domenica Lorusso (Rome, Italy)
Room
Auditorium 1A
Date
Fri, 17.06.2022
Time
14:50 - 15:50
Clinical trial highlights Special session

ATHENA (GOG-3020/ENGOT-ov45): A randomized, phase III trial to evaluate rucaparib as monotherapy (ATHENA-MONO) and rucaparib in combination with nivolumab (ATHENA-COMBO) as maintenance treatment following frontline platinum-based chemotherapy in ovarian cancer

Lecture Time
10:40 - 10:50
Speakers
  • Rebecca Kristeleit (London, United Kingdom)
Room
Auditorium 1A
Date
Sat, 18.06.2022
Time
10:30 - 12:00
GSK - Using biomarkers to guide targeted therapy in gynaecological cancers Industry satellite symposium

Welcome and introduction

Lecture Time
13:00 - 13:05
Speakers
  • Ana Oaknin (Barcelona, Spain)
Room
Auditorium 1A
Date
Fri, 17.06.2022
Time
13:00 - 14:00
Management of endometrial cancer in the molecular era Educational session

Recent developments in surgery for early-stage disease

Lecture Time
08:35 - 09:00
Speakers
  • Christian Marth (Innsbruck, Austria)
Room
Auditorium 1A
Date
Fri, 17.06.2022
Time
08:30 - 10:00
Welcome to the ESMO Gynaecological Cancers Congress 2022 Welcome and closure

Welcome to the ESMO Gynaecological Cancers Congress 2022

Lecture Time
08:30 - 08:35
Speakers
  • The Panelists (Valencia, Spain)
Room
Auditorium 1A
Date
Fri, 17.06.2022
Time
08:25 - 08:30
Managing the consequences of cancer treatments Clinical case session

Fertility-preservation option in gynaecogical cancer

Lecture Time
14:15 - 14:35
Speakers
  • Frederic Amant (Leuven, Belgium)
Room
Auditorium 1A
Date
Sat, 18.06.2022
Time
14:15 - 15:45
Mini Oral session Abstract session

Invited Discussant of abstract 20MO

Lecture Time
13:05 - 13:15
Speakers
  • Jean Emmanuel Kurtz (Strasbourg, France)
Session Name
Room
Auditorium 1A
Date
Sat, 18.06.2022
Time
13:00 - 14:00
Clinical trial highlights Special session

Invited Discussant of SIENDO/ENGOT-EN5 and MITO 23 studies

Lecture Time
11:35 - 11:50
Speakers
  • Isabelle L. Ray-Coquard (Lyon, France)
Room
Auditorium 1A
Date
Sat, 18.06.2022
Time
10:30 - 12:00
Keynote lecture: Changes in practice and research breakthroughs in the treatment of gynaecological cancers Keynote session

Changes in practice and research breakthroughs in the treatment of gynaecological cancers

Lecture Time
14:20 - 14:40
Speakers
  • Eric Pujade-Lauraine (Paris, France)
Room
Auditorium 1A
Date
Fri, 17.06.2022
Time
14:15 - 14:45
The evolving landscape in cervical cancer treatment Educational session

Is immunotherapy ready for prime time in cervical cancer?

Lecture Time
08:55 - 09:20
Speakers
  • Domenica Lorusso (Rome, Italy)
Room
Auditorium 1A
Date
Sat, 18.06.2022
Time
08:30 - 10:00